Studies on stigma in Parkinson’s disease in the world. A literature review
Objective: To demonstrate the geographical distribution of studies among populations, and to summarize factors associated with stigma in Parkinson’s disease (PD). Background: One of the…TWNK in Parkinson’s disease: a Movement Disorder and Mitochondrial Disease Center perspective study
Objective: The aim of the study was to screen for TWNK variants in an Italian cohort of Parkinson’s disease (PD) patients, and to assess the…Relationship between brain bioelectrical activity during REM/NREM sleep, grey matter changes and visual disorders in patients with RBD in Parkinson’s disease
Objective: To investigate the brain bioelectric activity during REM/NREM sleep and determine the relationship with visual impairment and structural brain alteration in non-demented PD patients…Altered brain dynamics in Parkinson’s disease patients treated by deep brain stimulation
Objective: The presented work explores electrophysiological changes in brain dynamics described by EEG microstates and the effect of deep brain stimulation (DBS) of subthalamic nucleus…COMT polymorphism as a genetic factor in levodopa-induced dyskinesia development in Russian patients with Parkinson’s disease
Objective: We examined the influence of single nucleotide polymorphisms (SNPs) in specific genes on levodopa-induced dyskinesia development in Parkinson’s disease patients Background: Levodopa-induced dyskinesia (LID)…JourneyMap: A visual resource to reduce coordinator burden during virtual study visits
Objective: Reduce burden on research team members and study participants during remote deployment of a touchless sensor device for in-home use with people with Parkinson’s…Virtual Visit Experience of the Portland Oregon Pacific UDALL Center During COVID-19
Objective: To retain a well-characterized longitudinal Parkinson’s Study, The Portland Oregon Pacific UDALL Center (PRE-PUC) cohort, during the pandemic years. Background: Although best known for…Environmental exposures and clinical phenotype in a sample of patients with Parkinson’s disease in the southwestern Colombian region: preliminary results
Objective: Describe the clinical phenotype and environmental agents of patients from the Colombian southwestern region with familiar and sporadic Parkinson’s disease in a sample Background:…Alteration of the fecal microbiota in Turkish patients with idiopathic Parkinson’s disease
Objective: To determine whether the gut microbiota is altered in Turkish patients with Parkinson Disease (PD) and the potential effect of gut microbiota on pre-motor…IncobotulinumtoxinA for treating chronic sialorrhea due to Parkinson’s disease and other neurological conditions
Objective: To summarize clinical experience with incobotulinumtoxinA (INCO) for treating chronic sialorrhea due to Parkinson’s disease (PD), atypical parkinsonism, stroke, or traumatic brain injury in…
- « Previous Page
- 1
- …
- 239
- 240
- 241
- 242
- 243
- …
- 338
- Next Page »